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Abstract

ADAPTATION AT A SHORTENED LENGTH IN RABBIT FEMORAL ARTERY
By Melissa L. Bednarek, B.S., M.P.T.
A Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.

Virginia Commonwealth University, 2009

Major Director: Paul H. Ratz
Professor, Departments of Biochemistry and Pediatrics

It is well known that the overlap between the thick and thin filaments in striated
muscle is responsible for the single active length-tension (L-T) curve. With the lack of
visible striations, a sarcomeric unit has not been identified in smooth muscle. Though
once thought to function like striated muscle via a sliding filament mechanism of
contraction, recent studies on length-adaptation (L-adaptation) in airway smooth muscle
(ASM), in which increased tension is generated with repeated contraction, have led to the
hypothesis of a dynamic L-T curve in smooth muscle. Although more established in ASM,
two studies have shown L-adaptation in vascular smooth muscle (VSM). In this project,
the L-T curve over a 3-fold length range in rabbit femoral artery was investigated and the
presence of more than one active and passive L-T curve was identified. The third of three
x

repeated KCL-induced contractions at a single, shortened length resulted in L-adaptation in
which the phasic and tonic phases of contraction demonstrated a 10-15% increase in active
tension (Ta) relative to the first contraction. Experiments investigating possible
mechanism(s) responsible for this phenomenon demonstrated that neither an increase in
[Ca2+]i nor an increase in MLC20 phosphorylation was responsible for the increased
tension. However, actin polymerization did appear to play a role in the L-adaptation of
both phases of contraction. Thus directions for future research could include further study
of actin polymerization in VSM that contributes to L-adaptation and may ultimately result
in artery remodeling.

xi

CHAPTER 1
Introduction
1.1 Smooth Muscle Physiology
The common function of all muscles is to contract. Contraction of skeletal muscle
results in movement of bones while contraction of cardiac and the great majority of smooth
muscles results in hollow organ dimensional changes. In particular, the smooth muscle
contained in the walls of the vascular tree is responsible for regulating the diameter of the
vessel. Changes in diameter and tension are possible through contraction of vascular
smooth muscle (VSM).
As in striated muscle, calcium (Ca2+) plays a key role in the mechanism of smooth
muscle contraction. Voltage-operated Ca2+ channels (VOCs) open with depolarization of
the smooth muscle membrane, thus allowing for the influx of Ca2+ down its concentration
gradient (Figure 1.1). Calcium will then bind cooperatively with calmodulin, and the Ca2+calmodulin complex activates myosin light chain kinase (MLCK). Through its kinase
activity, MLCK phosphorylates the 20 kDa regulatory light chain of myosin (MLC20) thus
facilitating interaction with actin and formation of tension-generating crossbridges. In the
presence of ATP, contractions occur until MLC20 is dephosphorylated by myosin light
chain phosphatase (MLCP). Through actin connections to dense bodies and ultimately to
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FIGURE 1.1: Diagram of Mechanism of Smooth Muscle Contraction
Diagram illustrating the mechanism of smooth muscle contraction, from activation through
transmission of generated tension to the extracellular matrix. Also shown is the regulation
of MLCP by ROCK and PKC as well as the regulation of MLCp by PKC.
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the adhesion junction at the cell membrane, the tension generated by the crossbridges is
transmitted to the extracellular matrix [15].
In addition to VOCs that open with membrane depolarization, there are additional
routes through which Ca2+ may enter a smooth muscle cell. Chief among these routes are
receptor-operated Ca2+ channels (ROCs) and store-operated Ca2+ channels (SOCs). When
a neurotransmitter or hormone, such as norepinephrine, activates a G-protein coupled
receptor (GPCR) additional cation channels, including ROCs and SOCs are opened. In the
history of smooth muscle research, both depolarization and activation of GPCRs have been
utilized as a means to activate tissue [99]. The stimulus utilized to depolarize is typically a
high concentration potassium (K+)-solution. The presence of additional extracellular K+
will prevent movement of intracellular K+ down its concentration gradient and thus result
in membrane depolarization and opening of VOCs to initiate smooth muscle contraction.
An advantage of tissue activation through depolarization is that GPCR and downstream
signaling pathways are not activated, which has led to new information on Ca2+-sensitivity
of contraction [79].

1.2 Phases of a VSM Contraction
Upon activation, VSM demonstrates a characteristic biphasic contraction. The
initial rapid rise in tension, phasic phase, is complete within approximately 10 sec after
stimulation while the slow rise in tension, tonic phase, requires an additional 2-3 min to
develop [103] (Figure 1.2). Conditions such as stimulus concentration and temperature
have been shown to differentially affect these two phases[20, 103, 123].
3

12

Phasic

Tension (g)

10

Tonic

8
6

Ta

4
2
Tp

0
0

2

4

6

8

10

Time (min)
FIGURE 1.2: Representative Tension Tracing of Rabbit Femoral Artery Contraction
Representative time versus tension tracing for a K+-induced rabbit femoral artery
contraction. The development of the phasic phase active tension (Ta) is very rapid and
brief while the development of the tonic phase Ta is slower and sustained. Also, note that
total muscle tension is the summation of Ta and passive tension (Tp). Passive tension will
be further discussion in Section 1.4.
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Although the mechanism responsible for each phase of a VSM contraction is not fully
known, some models have been proposed. K+-induced VSM contractions are dependent
on the influx of extracellular Ca2+ [42, 120] and there is evidence that each of the phases
may be due to a different type of Ca2+ channel [43]. Extracellular Ca2+ may act in
conjunction with depolarization-activated intracellular Ca2+ pools to generate tension [6,
55] and different sources of Ca2+ may be responsible for the different phases of contraction
[81, 123].
Regardless of the source, it is generally accepted that a rise in myoplasmic Ca2+ levels
is responsible for the phasic phase of smooth muscle contraction. What is less understood
is the mechanism for sustained tension in the tonic phase with falling levels of myoplasmic
Ca2+ and MLC20 phosphorylation [19, 45]. A model proposed by Murphy and colleagues
to explain these findings is the latchbridge hypothesis [17, 35]. In this model, following
muscle activation, crossbridges are dephosphorylated yet remain attached to create
latchbridges that are capable of maintaining tension. Another model proposed to explain
the maintenance of tonic force with decreased MLC20 phosphorylation invokes structural
stability [78]. This model describes membrane activation of a Ca2+-sensitive protein
kinase C (PKC) that is able to phosphorylate intermediate filament proteins, such as
desmin, and actin-binding proteins, such as filamin. When phosphorylated, filamin is able
to interact with actin to provide a stable internal structure, and thus tonic force is
maintained. Additional support for the involvement of PKC and actin in tonic force
maintenance comes from the work of Wright and Hurn[123]. Low concentrations of the
PKC inhibitor staurosporine or use of cytochalasin D, known to cap the (+) end of
5

filamentous actin (F-actin), selectively inhibits the tonic phase of a K+-induced contraction
of rat aorta.

1.3 Role of VSM in Regulation of Blood Pressure
A certain level of arterial blood pressure is required for adequate tissue perfusion.
Because there is insufficient cardiac output to fully perfuse all vascular beds, blood flow
must be regulated. Changes in cardiac output and total peripheral resistance (TPR) will
result in changes in blood pressure. There are two main systems responsible for sensing
and responding to changes in arterial blood pressure [15]. The first system is a quickresponse system and involves baroreceptors located in the walls of the carotid sinus and
aortic arch. With changes in blood pressure, there are changes in autonomic output to the
heart and blood vessels. The effect of a decrease in blood pressure on VSM involves an
increase in sympathetic activity, release of periarterial norepinephrine, activation of
GPCRs causing vasoconstriction and an increase in TPR that will facilitate a compensatory
rise in arterial blood pressure. The second system, the renin-angiotension II-aldosterone
(RAA), is slower-acting and will facilitate a compensation for a decrease in blood pressure
through its actions on the adrenal cortex, kidneys and vasculature. Although this system
primarily involves changes in blood volume through the action of angiotension IIstimulated release of aldosterone, a secondary effect of angiotension II is vasoconstriction
of arterioles. Thus, along with the heart and kidneys, the vascular system plays a role in
the regulation of arterial blood pressure.

6

The regulation of blood pressure through changes in TPR occurs primarily at the level
of the arteriole. Along with cardiac output, TPR determines the steady component of
blood pressure [65]. A second component of blood pressure, the pulsatile component, is
determined by ventricular ejection, large artery compliance and timing of reflected waves
[65]. Thus, there are roles for both the microcirculation and macrocirculation in the
regulation of blood pressure.
Based on their location in the vascular tree, a function of large arteries is to translate
the intermittent pressure increase and resultant ejection of blood from the heart into a
constant pressure and perfusion for distal tissues [87, 88]. This occurs through the
“Windkessel” effect in which part of the stroke volume ejected during systole is
immediately conducted distally while the other part is stored within the elastic vessel wall
to be conducted during diastole. Based on their different functions, the smaller peripheral
arteries are stiffer and thus conduct pulse waves faster than the larger central arteries.
Thus, a forward-traveling pressure wave will ultimately meet stiffer arteries and generate a
backward-traveling reflection pressure wave. The forward- and backward-traveling waves
will summate to provide pulse pressure amplification down the vascular tree and, centrally,
increase coronary artery perfusion during diastole. Any change in this balance of arterial
stiffness, such as may occur with normal aging or pathology such as hypertension, will
result in impaired blood flow. Over time, these changes can result in pathologic
remodeling that includes an increase in vessel wall diameter with a decrease in lumen
diameter[26, 89]. Thus, VSM in both small and large arteries play a critical role in the
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regulation of arterial blood pressure. Rabbit femoral artery, a medium-sized muscular
artery, was used for this project.

1.4 Passive Length-Tension (L-T) Relationship in Skeletal and Smooth Muscle
As a component of measured total tension, the passive tension (Tp) exerted by muscle
plays an important role in muscle biomechanics. Therefore, the effect of length on Tp
should be considered. Using isolated frog skeletal muscle fibers, Lakie and Robson [51]
demonstrated that the length-history in the relaxed state was important in the passive
tension that the fiber was able to develop. When the magnitude of the length response to a
tension was compared with the response to the same tension applied following a period of
length-oscillations, the latter length response was found to be approximately eight times
larger. For a maximal increase in the post-oscillation response, a series of six to nine
length oscillations were necessary. The magnitude of a third response decreased as the
time interval between the second and third tension increased. This effect was attributed to
crossbridge interactions. Using a permeabilized rabbit psoas muscle preparation,
Campbell and Moss [10] later investigated length-history dependency of skeletal muscle in
the presence of controlled levels of Ca2+. Based on the investigators’ definition of
thixotrophy as “a time-dependent reduction in a muscle’s resistance to stretch following
movement,” they found that muscle stiffness increased with increase levels of free Ca2+.
Thus, the link to [Ca2+]i provided additional evidence for a role of cycling crossbridges in
generation of Tp. This work was later expanded to suggest a role for crossbridges in Tp
generation in cardiac muscle [11].
8

Despite the inherent complexity in VSM, such as the presence of basal tone and the
large amount of connective tissue in the vessel wall, some have investigated Tp generation
in VSM following length changes. One such study was that completed by Herlihy and
Murphy [37] in which they set out to more fully characterize the passive and active tension
of hog carotid artery over a series of lengths. They noted that different L-Tp curves could
be obtained dependent on the protocol used to obtain Tp. The authors suggested that a
series of stretches to a maximal length followed by release to shorter length provide the
best estimate of Tp. Thus, the length-history of VSM affects Tp generated at a particular
length. Wingard et al. [121] expanded on this work using a similar protocol to obtain Tp
and also found the presence of two Tp curves. The Tp generated with gradual tissue
lengthening exceeded that generated with gradual shortening and the authors attributed the
difference in curves to an irreversible increase in the compliance of the tissue in contact
with the steel mounting posts (Figure 1.3). Thus, following maximal stretch, the length of
viable tissue capable of contributing to the Tp, as well as active tension (Ta), is reduced.
Others have suggested a possible role for Ca2+-independent crossbridges or passive
structures as responsible for resistance to stretch [82].
More recent work by Speich and colleagues [100, 101] demonstrated that strips of
rabbit detrusor smooth muscle displayed both a viscoelastic component and a strainsoftening (SS) component following length-oscillations under passive conditions. They
determined that the viscoelastic component was reversible with time while the SS
component, initially thought to be irreversible, returned following muscle activation.
Furthermore, the amount of stiffness that returned upon activation was found to be
9

A.

B.

Steel Post

Tissue Damage
After Maximal Stretch

FIGURE 1.3: Diagram of Increased Tissue Compliance Evident with Stretch
Panel A illustrates that, when an artery ring is viewed end-on, there is a certain amount of
tissue in contact with the steel mounting post. Following maximal stretch, this tissue is
thought to be irreversibly damaged and thus, due to its position in series with the viable
contractile tissue, increase the tissue compliance as shown in Panel B. Thus, in effect, the
length of viable tissue is reduced following stretch to maximal length.
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dependent on the muscle length at the time of activation. Thus, their work provided
additional evidence for a role for crossbridges in the generation of Tp. A novel finding of
this study was the involvement of Rho kinase (ROCK), as the return of SS-induced Tp was
prevented in the presence of a ROCK inhibitor.
The studies just described involved a series of length changes prior to measurement of
Tp. Experiments on airway smooth muscle (ASM) in rabbit investigated the effect of static
changes in length on Tp [117]. When relaxed tissues were set for 24 h at lengths longer or
shorter than a reference length, the shape of the subsequent passive L-Tp curve was similar
to the reference but was shifted on the length-axis, to the right for tissues set at longer
lengths and to the left for tissues set at shorter lengths. Thus it appears that ASM is
capable of adapting to length changes with extended time at a particular length. This
characteristic has been termed length-adaptation (L-adaptation).

1.5 Active L-T Relationship in Skeletal and Smooth Muscle
Through visualization of sarcomeric units, early work on skeletal muscle fibers
demonstrated that the isometric tension generated by muscle activation was directly
correlated to the amount of contractile filament overlap [29, 44]. Using a systematic
approach in their now classic work, Gordon et al. [29] demonstrated the full L-T curve in
frog skeletal muscle fibers. They reported that tension generation was nearly constant at
sarcomere lengths from approximately 2.0 µ to 2.25 µ. Tension fell sharply at lengths both
shorter and longer than those identified as the plateau, such that tension generation was
only possible between lengths of 1.27 µ and 3.65 µ. This characteristic L-T relationship
11

was explained using the sliding filament mechanism of contraction. They suggested that
each interaction between a thick and thin filament is able to generate a fixed amount of
tension and the tension generated by the fiber as a whole is dependent on the amount of
overlap between thick and thin filaments and thus the number of interactions. Based on
the similar shape of the L-Ta curve, later experiments on smooth muscle strips provided
evidence for a sliding filament mechanism of contraction similar to that just described for
striated muscle [30, 37].
It has long been known that smooth muscle can contract over a large length range
[122], although not all exhibit the dramatic 7-fold length change possible in urinary
bladder smooth muscle [113]. Consistent with this idea, Herlihy and Murphy [37] noted
that arterial strips generated tension at proportionately shorter muscle lengths than in
skeletal muscle. Mulvany and Warshaw [63] later estimated that the working range of
VSM was 0.38-fold L0 to 1.82-fold L0, where L0 is the length at which the tissue is able to
generate maximal tension. When relaxed, isolated smooth muscle cells stretched to
lengths greater than resting produced similar forces to that achieved at resting length,
Harris and Warshaw [36] interpreted these findings as evidence for a broad plateau in the
L-Ta relationship. In VSM, the plateau has been shown to range from 0.9-fold L0 to 1.19fold L0 [121].
The large length range over which smooth muscle has been shown to generate
tension has called into question a static sarcomeric structure that is known to exist in
skeletal muscle. As a sarcomeric-like unit has yet to be visualized in smooth muscle,
alternative explanations for the observed L-Ta relationship have been put forth. An
12

element common to these explanations is the dynamic nature of the smooth muscle cell,
contractile filament structure and/or actin cytoskeleton.

1.6 Terminology Related to the L-T Relationship in ASM
With advantages such as minimal connective tissue and the parallel arrangement of
cells, ASM has been found to be ideal for the study of smooth muscle biomechanics [97].
Before further discussion of the dynamic nature of tension generation in smooth muscle, a
brief discussion of agreed upon terminology in the field of ASM biomechanics and the
application to this project is warranted.
With the expansion of the field over the past two decades, a group of over 40
researchers published an editorial in 2004 in which areas of current confusion in
terminology were discussed as well as recommendations for standard terminology
suggested [3]. The concept of a maximal/optimal force, L0, achieved at a single length
seems inappropriate, at least for ASM. These researchers determined that ASM can adapt
to lengths shorter and longer than a reference length by developing additional tension, and
therefore suggested using terminology such as “in situ length” or “arbitrarily chosen
reference length.” These researchers also suggested that the term L-adaptation be used to
refer to “time-dependent force recovery and the subsequent shift in the length-force
relationship.” While it is now clear that ASM can L-adapt, the possibility that VSM can
likewise readjust the degree of Ta when moved away from L0 remains controversial.
For this project, L0 was defined as the muscle length at which the Tp was 13% ±3% of
the Ta (unpublished observation of PH Ratz) at that particular length. The protocol used to
13

obtain this length was very reproducible and was modified from two studies on VSM by
Murphy and colleagues [37, 121]. The protocol is more fully described in the Materials
and Methods section. For the purpose of this project, L-adaptation was defined as
increased tension generated upon repeated activation at a single length.

1.7 L-adaptation of Ta in Smooth Muscle Involves Changes in Myofilament Structure
One idea that first emerged in the mid-1990’s to explain the long range of smooth
muscle function was structural changes that occur in the contractile filaments with length
changes [24, 74]. With the inability to visualize the contractile structures, these
investigators used indirect measures of function to gain insight into ASM. With muscle
lengthening at constant activation, they found a decrease in velocity of shortening
proportional to an increase in tension [24, 93]. The model proposed by these investigators
to explain these findings was based on the knowledge that tensions generated by
crossbridges positioned in parallel add while crossbridges positioned in series increase
speed of shortening. More specially, they hypothesized that as muscle length increases so
too does the number of contractile units in series [24].
Additional support for a model in which thick filaments, specifically, transition from a
parallel to series arrangement with increasing muscle length can be found in pioneering
work performed 40 years ago that demonstrated that thick filaments were capable of
assembling upon muscle activation and partially dissolving upon muscle relaxation [85].
Evidence of an increase in myosin filament density with activation came from studies with
rat anococcygeus muscle [27, 28, 124] that were later corroborated by porcine ASM
14

studies that showed that the time necessary for thick filament polymerization could
account for the mechanical properties of adaptation [98]. The degree to which thick
filaments polymerize upon activation appears to be tissue dependent, as the thick filament
density in the rat anococcygeus increased 23% [124] upon activation compared to the
144% increase in porcine ASM [39]. Kuo et al. [50] demonstrated that an oscillationinduced decrease in thick filament density could be reversed with repeated contraction.
This group later suggested that it is the length of the ASM that regulates the amount of
thick filaments present in the cell [49].
To further the role that the thick filaments may play in this dynamic process of Ladaptation, Seow suggested that their formation may be guided by the thin filament
network [92]. Indeed, in vitro studies in Dictyostelium have shown that the interaction
between myosin monomers and fully-formed thin filament networks accelerates the rate of
polymerization of myosin [54]. A later study suggested that phosphorylation of the MLC
may regulate the thin filament-mediated myosin polymerization [1]. Thus, attention was
turned to the actin thin filament network and its regulation.
There is a large amount of actin present in smooth muscle. Cohen and Murphy [12]
found significantly higher actin content in pig arterial tissues (carotid, thoracic aorta and
left anterior descending coronary arteries) as compared to nonarterial smooth muscle
tissues (esophagus, trachea, intestine and uterus). With further investigation of arteries of
different sizes, no differences in actin, myosin or tropomyosin content was found [13].
Four types of actin are known to exist in smooth muscle: α-smooth muscle, γ-smooth
muscle, β-non-muscle and γ-non-muscle [23, 115]. Some have suggested that the relative
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amount of each type of actin in smooth muscle tissue relates to the amount of contractile
activity of the tissue [23]. Some actin filaments are engaged with myosin for the formation
of tension-generating crossbridges while other actin filaments provide structural stability to
the cell through connections to dense bodies and adhesion junctions. Attempts to assign
different functions to the different actin isoforms have met with varying results as Drew et
al. [18] found polymerization of the isoforms to be random in swine stomach while North
et al. [66] and Kim et al. [47] found the isoforms to localize to specific areas of smooth
muscle cells.
Regardless of actin isoform specificity, it was necessary to determine if, like the
myosin thick filaments, actin thin filaments polymerize upon activation. Using different
techniques, Mehta and Gunst [57] and Herrera et al. [40] confirmed that indeed actin
polymerization does occur with activation of ASM with the latter group showing that both
myosin and actin polymerization are length-sensitive. One of the techniques used by
Mehta and Gunst [57] involved use of latrunculin A and cytochalasin D. Latrunculin A is
a naturally occurring agent that has been shown to bind with globular actin, G-actin,
monomers in a 1:1 ratio and thus impair the ability of a smooth muscle cell to recruit Gactin for polymerization [16]. As reviewed by Cooper [14], cytochalasin D is a naturally
occurring agent that binds to the barbed end of filamentous (F)-actin at low concentrations
(0.2 µM) while it binds to G-actin monomers at higher concentrations (2-20 µM). In their
experiments on canine ASM strips, Mehta and Gunst found that tension declined in a dosedependent manner in the presence of either agent while the presence of latrunculin A had
no effect on MLC phosphorylation but the presence of cytochalasin D resulted in a dose16

independent decline in MLC phosphorylation as compared to untreated control strips. The
findings regarding the effect of muscle length on MLC phosphorylation had previously
been shown by Youn et al. [126]. With the ability to clamp calcium levels through the αtoxin permeabilization technique, Mehta and Gunst confirmed that the effect of
cytochalasin D on MLC phosphorylation was not mediated through changes in calcium
signaling. Another important result of their work pertained to the length-dependent
sensitivity of actin polymerization inhibitors. When muscle strips were contracted with
and without latrunculin A at L0, 0.8 L0 and 0.6 L0, there was significantly more tension
inhibition at the longer lengths. Thus the effect of muscle length on tension generation is
lost in the presence of latrunculin A yet retained in the presence of cytochalasin D.
Despite the useful information gained from mechanical studies of isometric contraction
using muscle strips or rings, it is important to consider the in vivo environment of the
tissues in the whole animal. To that end, some have conducted studies on arteries that are
cannulated and pressurized to create isobaric conditions. Versus the measurement of Ta
generated with an isometric contraction using a wire myograph setup, the lumen diameter
is measured upon stimulation in a pressure myograph setup. An important study
illustrating possible differences in the behavior of small arteries under isometric and
isobaric conditions was completed by Buus et al. [8]. They showed that although there
was no difference in the Tp relationship using a wire versus pressure myograph, there were
differences in the active responses. When activated through α-1 adrenergic receptor
agonist noradrenaline or phenylephrine, pressurized vessels showed an increased
sensitivity to stimulation that was dose dependent. However, when the GPCR system was
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bypassed with use of K+-stimulation, there were no differences between experimental
methods. Similar responses to norepinephrine were found in rat [22]and rabbit [21]
mesenteric arteries. These effects, however, may be related to the small size of the arteries
studied as Tanko et al. [111] showed that medium size porcine coronary arteries are more
sensitive to agonist and K+-stimulation under isometric versus isobaric conditions. Taken
together, these results illustrate that care should be exercised when interpreting results of
isometric arterial studies as representative of the in vivo condition.
With this in mind, inhibitors of actin polymerization have been used in the in vivo-like
pressurized model. Using small rat mesenteric arteries and isobaric conditions, Shaw et al.
[94] demonstrated that, as in isometric conditions, there is a concentration-dependent
decrease in vasoconstriction with agonist stimulation in the presence of cytochalasin D. In
their studies with latrunculin B, these authors found a concentration-dependent decrease in
the sustained agonist-induced vasoconstriction but not the peak phase. While it appears
that the peak and sustained phases of contraction were inhibited equally at all tested
concentrations of cytochalasin D (0.1 µM to 5.0 µM), the differential effect of latrunculin
B on the phases increased with the higher concentrations tested. Furthermore, these
authors showed that these reductions in vasoconstriction were not due to alteration of
[Ca2+]i, as measured with the calcium indicating dye indo-1. A reduction in sustained
vasoconstriction with no effect on [Ca2+]i was found upon K+-stimulation in the presence
of cytochalasin D and latrunculin B. The authors did not comment on the effect of phasic
K+-induced tension in the presence of the inhibitors. Thus studies with acetylcholine [57],
α-adrenergic [94], and K+-stimulation [94, 112] show no change in [Ca2+]i in the presence
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of cytochalasin, however, a simultaneous decrease in tension and [Ca2+]i has been shown
with muscarinic stimulation [112].

1.8 L-adaptation of Ta in Smooth Muscle Involves Regulation of the Contractile
Apparatus
In addition to changes in the structure of the myosin and actin filaments per se, another
possible source for the length-dependent changes unique to smooth muscle might be found
in the regulation of activation of the actomyosin crossbridges. In the early 1980’s, Price
and colleagues [76] demonstrated a length-dependency in dog anterior tibial artery through
activation with agonist stimulation or depolarization. The optimal length of the artery,
Lmax, was determined as the length at which maximal Ta was generated with electrical field
stimulation. When compared to two shorter lengths and a longer length, they found that
arteries were most sensitive to stimulation at Lmax. With further attention to lengths greater
than Lmax, this group found that indeed sensitivity to norepinephrine stimulation continues
to increase as length increases [77]. They suggested that an increase in [Ca2+]i may be
responsible for the length-dependent sensitivity evident in VSM. Calcium was also
implicated in the reduced force development when activated ASM was moved to a
shortened length [31]. Furthermore, Rembold and Murphy [83] found that [Ca2+]i, as
measured with aequorin, decreased at lengths below L0. Thus the decreased myoplasmic
level of Ca2+ at lengths below L0 was thought to play a role in the decrease in tension at
shorter lengths. Although the results of Van Heijst et al. showed a sensitivity to αadrenergic stimulation that was dependent on length in intact tissues, especially in rabbit
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femoral artery, their experiments on skinned muscle did not show a change in Ca2+sensitivity to length [114].
Upon stimulation, [Ca2+]i in smooth muscle binds with calmodulin, thus forming a
complex capable of activating MLCK that will phosphorylate MLC20 and begin
crossbridge cycling. Thus, with the knowledge that [Ca2+]i is dependent on smooth muscle
length up to L0 [83] it was reasonable to next investigate what, if any, effect length has on
the level of MLC20 phosphorylation. Using swine carotid arteries and K+-stimulation, Hai
[34] measured both peak and steady-state MLC20 phosphorylation at slack length, L0 and
1.5 L0. Relative to L0, at the longest length there was a significant decrease in peak
phosphorylation while at slack length there was significant decrease in peak and steadystate phosphorylation. When two contractions at L0, separated by 1 hr of relaxation, were
completed there were no changes in peak or steady-state phosphorylation levels. This was
in contrast to the significant decrease in peak phosphorylation that was found in the second
contraction when the same protocol was completed on tissues at slack length. Thus, it
appears that the level of MLC20 phosphorylation that corresponds to the peak of
contraction is sensitive to lengths both above and below L0 while steady-state
phosphorylation is only sensitive at shortened lengths. In permeabilized swine VSM,
myosin phosphorylation levels were found to be insensitive to lengths shorter and longer
than L0 [61]. The decrease in MLC20 phosphorylation in tissues shorter than L0 is evident
in ASM stimulated with acetylcholine or K+ [59] as well as carbachol [125, 126]. In
contrast, Wingard et al. [121] showed similar levels of steady-state MLC phosphorylation
in K+-depolarized swine carotid arteries at lengths ranging from 0.6 L0 to 1.8 L0.
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1.9 L-adaptation of Ta in Smooth Muscle Involves Changes in the Regulation of the
Actin Cytoskeleton
When investigation of ASM stiffness, thought to be indicative of the number of
crossbridges participating in tension generation, demonstrated insensitivity to length,
Gunst et al. suggested a structure in series with the tension generating crossbridges may be
responsible for length dependent changes in smooth muscle [33]. One possibility for this
structure was the actin cytoskeleton. As the function of a smooth muscle cell is to generate
tension, which must then be transmitted to extracellular structures, Gunst and colleagues
have done much to elucidate important signaling involved in regulation of the actin
cytoskeleton in ASM over the past 15 years. Studies of cell signaling downstream of the
cell membrane thought to regulate the actin cytoskeleton will be briefly reviewed.
Integrins, located at the adhesion junction on the smooth muscle cell membrane, appear to
be a physical link between the extracellular matrix and cytosolic structures. These proteins
span the cell membrane and are capable of transducing chemical and mechanical signals
both from the extracellular matrix to the cytosol and vice versa [25]. From the results of
cell culture studies [7], the cytosolic kinase focal adhesion kinase (FAK) has been
implicated in signal transduction pathways through integrins. Also among the proteins
present at the adhesion junction is paxillin, which has been shown to be phosphorylated
upon activation of ASM and necessary for tension development [70, 73, 118]. At least in
vitro, FAK is capable of phosphorylating paxillin [5]. What is interesting to note is that
loss of FAK in ASM has been shown to decrease [Ca2+]i and MLC phosphorylation with
subsequent decrease in tension generation [106] while loss of paxillin affects tension
21

generation but apparently through a mechanism not involving [Ca2+]i and MLC
phosphorylation [108, 109]. Thus the possibility exists that mechanisms for crossbridge
cycling and actin polymerization diverge at the level of FAK. Phosphorylation of both
FAK and paxillin was length-sensitive upon activation of ASM, with trends mirroring the
L-T relationship in smooth muscle for lengths less than L0 [105]. An additional protein at
the adhesion junction, talin, is capable of binding directly to the cytoplasmic domain of
integrins as well as actin filaments [9, 90] while α-actinin is recruited to integrins with
ASM activation [127]. Thus, these early studies provided evidence for a role of membrane
proteins as signaling changes in muscle length.
Unlike the cell culture model in which early studies of adhesion signaling were based,
the small GTPase Rho does not appear to be an upstream regulator of FAK nor paxillin
phosphorylation [58]. However, another member of the family of small GTPases, Cdc42,
does appear to play a more upstream role in the regulation of actin polymerization in ASM.
Agonist stimulation in ASM has been shown to activate Cdc42, which may result in
regulation of actin polymerization through activation of neuronal Wiskott-Aldrich
syndrome protein (N-WASp) and actin-related protein complex (Arp 2/3) [107]. The
adaptor protein Crk II, known to interact with paxillin upon stimulation [108], has been
shown to regulate the activation of Cdc42 and thus, ultimately, N-WASp [110]. Moving
downstream to the level of actin filament nucleation by Arp 2/3 [41], N-WASp activation
of Arp 2/3 is necessary for actin polymerization in response to contractile stimulation
[128].
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Despite the lack of an upstream role for Rho in the transduction of extracellular signals,
Rho has been shown to be involved in regulation of actin polymerization. One of the
known effectors of Rho is Rho kinase (ROCK), a serine/threonine kinase. As one of its
many functions inside a cell, ROCK has been shown to phosphorylate Thr 508 of LIM
kinase 1 (LIMK1) which, when activated, is capable of phosphorylating and inactivating
cofilin [2, 53, 69]. Thus, activation of Rho and subsequently ROCK, LIMK1 and cofilin
will prevent the actin depolymerizing function of cofilin. A second known effector of Rho
is p140mDia, a member of the formin-related family of proteins that participate in cell
structure regulation, and is thought to interact with profilin [119]. In contrast to cofilin,
profilin has been shown to play a role in actin polymerization in the presence of thymosin
β4 [71]. Thus, it appears that Rho may participate in the stabilization of the actin
cytoskeleton via stabilization of cofilin and activation of profilin.

1.10

Studies of L-adaptation in VSM

As was presented, there is a significant amount of literature on L-adaptation in ASM
including possible mechanisms. There are, however, only two studies investigating the Ladaptive response of VSM to changes in length. In the first, using rabbit carotid artery and
electrical field stimulation, Seow [91] showed a decrease in isometric Ta upon activation 2
min following change to a length shorter or longer than the reference length (Lref). Ta
significantly increased when activated at the same length 27 min later. When Tp was
investigated, measurements 27 min after length change showed a decrease in stiffness as
compared to shortly after length change. Seow concluded that adaptation in Ta and Tp in
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VSM, although incomplete, was time dependent. Adaptation of Ta was evident through a
series of isometric contractions every 5 min throughout the recovery period. What does
not appear to be accounted for in this important study is the possible role that the repeated
contraction may have had on L-adaptation in VSM. A more recent study by the same
group investigated L-adaptation in sheep pulmonary artery [104]. As in the previous
study, a decrease in Ta was evident upon release of the muscle from Lref to either 0.8 or 0.6
Lref that improved over a 30 min period during which the muscle was activated every 5
min. Although there was improvement in Ta for muscle released to either shortened
length, only the muscle released to 0.6 Lref demonstrated a significant increase from
stimulation immediately upon release to the stimulation when fully adapted. Despite
smaller absolute values, the same pattern of recovery was evident for Tp as for Ta.

1.11

Project Objectives/Outline

Although the concept of smooth muscle L-adaptation is widely accepted in ASM, a
complete mechanism is still not known nor is the extent to which these findings can be
applied in other tissues. With the limited studies on L-adaptation in VSM in particular, the
early studies just presented have only begun to characterize L-adaptation. Lengthdependent changes in VSM tension generation are clinically important in the regulation of
arterial blood pressure, especially in light of conditions such as hypertension.
With the differing views of a static versus dynamic L-T curve in smooth muscle, it was
necessary to first characterize the full L-T curve in this preparation with a focus on
possible differential effects of length on the phasic and tonic phase of contraction. With
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appreciation for the role that Tp plays in generation of total force, the effect of lengthhistory on Tp was investigated. The L-adaptation of Ta present in VSM was then more
fully characterized, again with a focus on any differences in adaptation between the two
phases. The next goal was to investigate the role of crossbridge regulation on L-adaptation
through measurement of [Ca2+]i, and MLC20 phosphorylation. The role of [Ca2+]i was
further investigated through β-escin permeabilized tissue experiments in which [Ca2+]i was
tightly controlled. Using pharmacologic agents known to affect actin polymerization, a
possible role for this process in L-adaptation was also studied.
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CHAPTER 2
Materials and Methods
2.1

Tissue Preparation
All experiments involving rabbits were conducted within the appropriate animal

welfare regulations and guidelines and were approved by the Virginia Commonwealth
University Institutional Animal Care and Use Committee. In brief, adult New Zealand
White rabbits were pre-anesthetized prior to death through sternotomy, as the heart was
used for other investigations. Femoral arteries were carefully dissected out and cleaned of
adhering tissue and either used immediately or stored in physiological salt solution (PSS)
at 0-4˚C for later experimentation. The PSS composition was 140 mM NaCl, 4.7 mM KCl,
1.2 mM MgSO4, 1.6 mM CaCl2, 1.2 mM Na2HPO4, 2.0 mM morpholino-propanesulfonic
acid (adjusted to pH 7.4), 0.02 mM EDTA (to chelate heavy metals) and 5.6 mM Dglucose. Immediately prior to an experiment, the vessel endothelium was disrupted with a
roughened metal rod and the artery was cut into rings ranging from 2-4 mm in length. The
tissue was then secured between two pins in an aerated myograph tissue chamber (Danish
Myo Technology) or an aerated muscle chamber (Radnoti Glass Technology, Monrovia,
CA) containing PSS maintained at 37˚C. One pin was connected to a micrometer for
length changes while the other was connected to an isometric force transducer. With the
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exception of permeabilized tissue experiments, all tissues were activated through K+depolarization.

2.2 L0 Determination
With the exception of the full L-T curve protocol, the optimum muscle length for
each tissue was determined using an abbreviated L-T curve protocol adapted from the
work of Murphy and colleagues [37, 121] (Figure 2.1). With a 0.5 g load, tissues were
first warmed to 37˚C for 30-60 min followed by a 5 min K+-induced contraction to
determine tissue viability (wake-up). Tissues were then washed in PSS and allowed to
relax for 15 min. Based on the maximal Ta achieved for each tissue during wake-up, the Tp
that would be 13 ± 3% of the Ta was calculated (release value). Tissues were then
stretched in 0.5 g increments and allowed to stress relax for 5 min before the next stretch.
Tissues were stretched to a load 1 g above the release value and then quick-released to
break any crossbridges. Following 15-30 seconds at the released value, tissues were again
activated for 5 min followed by a wash in PSS for 15 min. The Tp obtained following
release and just prior to contraction and the maximal Ta obtained during contraction were
used to calculate the release value for the second L0 determination. A minimum of two L0
determinations were completed prior to each experimental protocol.
With the exception of the full L-T curve protocol and the Tp protocols, all studies
were conducted in the presence of 1 µM phentolamine to block potential α-adrenergic
receptor activation caused by release of norepinephrine from periarterial nerves. All
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FIGURE 2.1: Representative Tension Tracing for L0 Determination
Representative time versus tension tracing for a wake-up contraction followed by 3 L0
determinations. Note that an L0 determination consists of a series of 0.5 g stretches,
release to a shorter length (to determine Tp) followed by muscle activation (to determine
Ta) and then relaxation. The ratio of Tp to Ta is calculated with a goal of 13 ± 3%. A
minimum of 2 L0 determinations were completed before each experimental protocol where
indicated.
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tension experiment data was then normalized to the steady-state tension achieved at 1.0 L0
in the presence of 1 µM phentolamine. Data was acquired through an analog-digital
converter board (National Instruments) and analyzed using DasyLab 8.0 (DasyTech,
Amherst, NH).

2.3 [Ca2+]i
Simultaneous tension and [Ca2+]i were measured in femoral artery rings. Following
L0 determination, tissues were loaded for 2 h with 7.5 µM fura-2-PE3 (acetoxymethyl
ester) and 0.01% (w/v) Pluronic F-127 to enhance solubility. Fluorescence emission
intensities at 510 nm collected by a photomultiplier tube were expressed as excitation
ratios (340/380 nm, DeltaRam V; Photon Technology International, Lawrenceville, NJ)
using Felix software (Photon Technology International). Background fluorescence,
determined by incubating tissues in 4 mM MnCl2 plus 20 µM ionomycin, was subtracted
before calculating the fluorescence ratios. Tension data obtained was normalized to the
steady-state tension achieved at 1.0 L0 in the presence of 1 µM phentolamine while
calcium data normalized to the corresponding steady-state calcium signals.

2.4 Tissue Permeabilization
Following L0 determination, femoral artery rings were washed in a calcium-free
“relaxing solution” (RS) comprised of 74.1 mM potassium methanesulfonate, 4.0 mM
magnesium methanesulfonate, 4.0 mM Na2ATP, 4.0 mM EGTA, 5.0 mM creatine
phosphate, 30.0 mM PIPES adjusted to pH 7.1 with 1N KOH and ionic strength 0.18 with
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additional 0.5 M potassium methanesulfonate. Tissues were chemically permeabilized
with 100 µM β-escin for 45 min at 4˚C then 15 min at 30˚C. Treatment with β-escin at
low temperature has been shown to slow penetration and/or binding of β-escin to the
surface of smooth muscle membrane [56]. Following permeabilization, artery rings were
washed with RS and incubated for 20 min at 30˚C in RS containing 10 µM A23187, a Ca2+
ionophore that will deplete the sarcoplasmic reticulum Ca2+. Tissues were then activated
with a “contracting solution” (CS) that contained 1M CaCl2 stock added to RS in amounts
as determined by WEBMAXC [72] for a final pCa 6.0 and pH of 7.1. Tissues at L0 were
contracted in the presence of 1 µM phentolamine for 10 min prior to the start of the
protocol. All experimental data was then normalized to the steady-state tension achieved
with this contraction. After each contraction during an experimental protocol, tissues were
washed with mixture of RS and 10 µM A23187.

2.5 Western Blot
Phosphorylation of MLC20 was measured by Western blot analysis of artery ring
homogenates. In brief, artery rings at 0.75L0 or 1.25L0 and at basal or steady-state
contraction were quick-frozen in an acetone-dry ice slurry, thawed to room temperature in
an acetone mixture with 6% trichloroacetic acid, 10 mM dithiothreitol (DTT) and 30 mM
NaF, homogenized in a buffer containing 1% SDS, 10% glycerol, 20 mM DTT, 25 mM
Tris·HCl (pH 6.8), 5 mM EGTA, 1 mM EDTA, 50 mM NaF, 1 mM sodium orthovanadate,
20 µg/ml leupeptin, 20 µg/ml aprotinin, and 20 µg/ml (4-amidino-phenyl)-methanesulfonyl fluoride, heated, clarified by centrifugation, and stored at -20º C or immediately
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assayed for protein concentration. Proteins were separated by electrophoresis followed by
Western blotting. MLC20 was identified using p-Ser19-anti-MLC20 rabbit polyclonal
antibody and anti-MLC20 mouse monoclonal antibody (Sigma; St. Louis, MO) was
assessed to quantify loading accuracy.

2.6 Protocol for Full L-T Curve
Following equilibration, rather than an abbreviated length-tension curve to determine
L0, tissues were subjected to a full L-T curve protocol. Tissues were preconditioned with a
series of 10 1-g stretches maintained for 3 min each before release to slack length, Ls.
Tissues then underwent a series of three contractions at Ls with 5 min of relaxation in PSS
between each. Next, tissues were taken through a series of length changes, with the
number, relative step size and duration as indicated in Figure 2.2. After a 3 min period to
allow for equilibration following length change, tissues were contracted for 7 min and
relaxed for 5 min before the next length change. Note the smaller length steps at the top of
the L-T curve in an effort to identify L0 as accurately as possible. After Ta was obtained at
each length for loading (LD) and unloading (ULD), tissues were washed and incubated in a
calcium-free solution for 10 min. Tissues were then taken through the same length steps
LD and ULD as before and the Tp determined at each length. To allow for stress relaxation
with increasing lengths and to ensure that a true Tp was measured, tissues were stretched to
0.05 mm above the desired length and allowed to stress-relax for 1 min prior to release to
the desired length where tissue was maintained for 2 min before next length change. As
stress relaxation is not a concern with decreases in length, tissues were released directly to
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FIGURE 2.2: Diagram of Full L-T Curve Protocol
Illustration of the full L-T curve protocol length-steps. The protocol included 3 min to
equilibrate to a new length, 7 min for muscle activation and 5 min for relaxation prior to
change to a different length. The number, duration and relative length of each step is
shown. Note that loading (LD) refers to increasing length steps while unloading (ULD)
refers to decreasing length steps.
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the desired length when descending the L-T curve. The steady-state Tp measurements at
each length obtained during LD, or ULD, were subtracted from the total tension
measurements obtained at the same length during LD, or ULD, to determine Ta. The
phasic and tonic Ta values and steady-state Tp values were obtained for each step and
normalized to maximal phasic Ta achieved upon LD.
A similar protocol was used to study the length-history dependence of Tp with the
following modifications. Following determination of L0 through an abbreviated L-T curve,
two contractions at L0 were completed followed by 2 contractions at slack length (Ls).
Next, in a set of two tissues, one tissue was pre-conditioned to maximal length of 1.42-fold
L0 while the other was not. Tissues were then taken through two series of LD and ULD at
lengths 0.8-fold L0, L0, 1.2-fold L0 and 1.4-fold L0 (Figure 2.3). To account for stress
relaxation during LD, tissues were stretched 2% above the desired length for 2 min prior to
release to desired length. Tp at L0 and one shorter and one longer length were then
compared. Only one measurement was obtained at 1.4-fold L0, thus there was no
comparison for LD and ULD available. Tissues were then contracted at Ls and L0 to
ensure viability following the series of stretches. All tissues were found to be viable at the
end of the protocol (data not shown).

2.7 Protocol for L-Adaptation at a Shortened Length
Following determination of L0 through an abbreviated L-T curve and a normalization
contraction at L0 in the presence of 1 µM phentolamine (T0), tissues were maintained either
at control length L0 or released to a shortened length 0.8-fold L0 for 5 min. Tissues then
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FIGURE 2.3: Representative Tension Tracing for Length-History Dependent Tp
Protocol
Representative time versus tension tracing, normalized to L0, for investigation of lengthhistory dependency of Tp. In Panel A, tissues were taken through two series (L1 and L2)
of length steps of 0.8-fold L0, L0, 1.2-fold L0, and 1.4-fold L0 during LD followed by ULD
(Tp at longest length only obtained once). In Panel B, tissues were first strain-softened
(SS) to length 1.42-fold L0 prior to the series of length steps.
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underwent a series of three K+-induced contractions at constant length, each of which was
10 min in duration followed by at least 15 min of relaxation in PSS (Figure 2.4). Phasic
measurements were obtained ~20 sec after activation while tonic measurements were
obtained 10 min after activation. This protocol was modified to include a stretch to 1.2 L0
or a contraction at the stretched length of 1.2 L0 between contractions 1 (T1) and
contraction 2 (T2) when investigating the role of intracellular structures on adaptation
(Figure 2.5). For studies involving the β-escin permeabilized tissue, this protocol was
again used with the Ta values obtained at steady-state.

2.8 Protocol for Drug Studies
Following determination of L0 through the abbreviated L-T curve protocol and a
normalization contraction at L0 in the presence of 1 µM phentolamine, all tissues
underwent a second 10 min contraction followed by 15 min relaxation prior to the
introduction of drug. Tissues were then incubated with vehicle, 2 µM latrunculin B (binds
G-actin monomers), 0.2 µM cytochalasin D (caps the (+) end of F-actin), 0.3 µM H-1152
(ROCK inhibitor) or 10 nM nifedipine (blocks L-type Ca2+ channels) for 15-30 min. The
vehicle/drug was then present in all subsequent buffer changes for the remainder of the
experiment. Following two contractions at L0, two tissues were incubated in vehicle while
two other tissues were incubated in drug. Following another two contractions, one tissue
in vehicle and one tissue in drug were released to a shortened length 0.8-fold L0 while the
other two remained at L0. All tissues then underwent a series of three contractions to
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FIGURE 2.4: Representative Tension Tracing for L-adaptation at a Shortened
Length
Length changes and representative time versus tension tracings for investigation of
adaptation at a shortened length. Panel A indicates that the length was held constant at L0
over the course of 4 contractions, with T0 as a reference contraction to which data was later
normalized. Panel B indicates that following T0, length was decreased to 0.8-fold L0 for 3
contractions.
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FIGURE 2.5: Representative Tension Tracing for Interruption of L-adaptation at a
Shortened Length
Length changes and representative time versus tension tracings for investigation of
interruption of adaptation at a shortened length. Panel A indicates that all contractions
were completed at a shortened length 0.8-fold L0 with a stretch to 1.2-fold L0 between T1
and T2. Panel B indicates that for some studies, the tissue was additionally contracted at
the stretched length of 1.2 –fold L0. T0 is a reference contraction to which data was later
normalized.
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investigate the effect of the vehicle versus drug with repeated contraction at a shortened
length (Figure 2.6).

2.9 Drugs
Phentolamine, β-escin and nifedipine were from Sigma, St. Louis, MO. A23187 was
from Fisher Scientific, Fair Lawn, NJ. Ionomycin was from LC Laboratories, Woburn,
MA. Fura-2-PE3 (acetoxymethyl ester) and Pluronic F-127 were from TEF Labs, Austin,
TX. Latrunculin B, cytochalasin D, H-1152, KN-92 and KN-93 were from Calbiochem,
La Jolla, CA. β-escin was dissolved in RS. Nifedipine and ionomycin was dissolved in
ethanol. A23187, latrunculin B, cytochalasin D and KN-92 were dissolved in dimethyl
sulfoxide (DMSO) and all other compounds were dissolved in deionized water. Ethanol
and DMSO were added at a final concentration no greater than 0.1%.
2.10 Statistical Analysis
Statistics were completed using either Microsoft Excel 2003 or Prism 3.0 (GraphPad
Software, San Diego, CA). The null hypothesis was examined using Student’s t test (when
two groups were compared) or using a one-way ANOVA (when more than two groups
were compared). To determine differences between groups after ANOVA, the StudentNewman-Keuls post hoc test was used. An exception was the Dunnett’s multiple
comparison test used to determine differences between Ta pre-drug to Ta post drug in the
presence of inhibitors of actin polymerization. In all cases, the null hypothesis was
rejected at p < .05. For each study described, the n value was equal to the number of
rabbits used in the study.
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FIGURE 2.6: Representative Tension Tracing for the Effect of Drugs on Ladaptation at a Shortened length
Representative time versus tension tracings for investigation of drugs on adaptation at a
shortened length. Panel A indicates that the length was held constant at L0 over 2
contractions prior to introduction of vehicle/drug, indicated with the arrow. Remaining
contractions at L0 were conducted in the presence of vehicle/drug. Panel B indicates that
following T3, tissue was shortened to 0.8-fold L0 for a series of 3 contractions (T4-T6).
Thus, the effect of length on VSM contraction in the presence of vehicle/drug was
investigated.
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CHAPTER 3
Results
3.1

Full L-T Curve
With differing thoughts on the static versus dynamic nature of the L-T curve in

VSM, it was necessary to determine the Ta and Tp over a 3-fold length change in rabbit
femoral artery preparation used for these studies. With an interest in the ascending limb
and plateau of the L-T curve, and referencing previous work that estimated these lengths,
the muscle lengths studied ranged from 0.38-fold L0 to 1.18 fold L0. Tp increased with
length, with steeper increases evident beyond length L0 (Figure 3.1A). Beginning at
shorter lengths, tissues generated increasing amounts of phasic and tonic Ta up to length
L0. Beyond L0, tension began to decrease. Although present in both phasic and tonic Ta
curves, a broad plateau was most evident in phasic Ta from 0.97-fold L0 to 1.09-fold L0.
When taken at the same length, two different Tp, phasic Ta and tonic Ta curves were
evident dependent on whether the tissue was being LD or ULD (Figure 3.1A and B).
Loading occurred when tissues were stretched to a longer length followed by equilibration,
activation, relaxation and stretch to a new longer length. Unloading occurred when tissues
were released to a shorter length, allowed to equilibrate, activated, and relaxed followed by
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FIGURE 3.1: Phasic and Tonic L-T Curves
Length versus tension over 3-fold length change in rabbit femoral artery. Panel A
illustrates the two curves obtained for phasic Ta and for Tp while Panel B illustrates the two
curves obtained for tonic Ta. Curves obtained either during either loading (LD) or
unloading ULD). ∗ indicates p< .05 LD versus ULD. n=4.
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release to a new shorter length. Differences between LD and ULD curves for all tensions
measured were significant at most lengths. Thus it appears that length- history, stretch
versus release, affects both Tp and Ta in rabbit femoral artery.
Phasic versus tonic Ta were further investigated at each length. At short lengths,
phasic Ta is greater than tonic Ta, while at lengths approaching L0, tonic Ta is greater than
phasic Ta. Thus, there is a crossover in the strength of phasic Ta and tonic Ta on the
ascending limb of the L-Ta curve (Figure 3.2A). When tissue is LD, this crossover occurs
at 0.73-fold L0 while it occurs at 0.90 -fold L0 when ULD (data not shown). This
relationship is further illustrated in Figure 3.2B as a rapid decrease in phasic Ta relative to
tonic Ta as lengths approach L0.
In conclusion, these data suggested that the phases of a rabbit femoral artery
contraction are differentially affected by muscle length. Additionally, length-history may
play a role as the crossover in the strength of the phases occurred at different lengths
dependent on LD versus ULD.

3.2 Length-History Dependency of Tp
The length-history dependency of Tp was further investigated in a separate set of
experiments. Tissues were either strain-softened (SS; Figure 3.3B) to the maximal length
for the protocol (1.42-fold L0) or were not SS (Figure 3.3A). Tissues were then LD and
ULD through two series of length-steps, Loop 1 (L1) and Loop 2 (L2). Lengths
investigated were 0.8-fold L0, 1.0-fold L0 and 1.2-fold L0. Tissues were allowed to
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FIGURE 3.2: Effect of Length on Phasic Ta and Tonic Ta
Length versus tension over 3-fold length change in rabbit femoral artery. Panel A
illustrates the crossover in Ta such that tonic Ta exceeds phasic Ta at lengths greater than
0.73-fold L0 during LD. Panel B further illustrates the sensitivity to length evident with a
rapid decrease in phasic Ta relative to tonic Ta at lengths approaching L0. n=4.
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equilibrate at each length before measurement of Tp. In tissues that were not SS, the Tp
obtained during L1 LD was significantly higher at L0 and 1.2-fold L0 when compared to the
same lengths of L1 ULD, L2 LD and L2 ULD. In tissues that were SS prior to L1, the only
significant difference was found between L1 LD and L2 ULD at length 1.0-fold L0.
Additionally, the Tp obtained at 1.2-fold L0 in the tissue with no SS was significantly
higher compared to the Tp obtained during L1 LD in SS-tissues.
Thus, Tp of rabbit femoral artery is dependent on length-history at lengths L0 and
longer. For lengths below L0, prior length-history does not appear to affect Tp. Also, for
tissues measured at long lengths, the presence of SS will result in a significant decrease in
Tp upon first LD as compared to tissues that were not SS.

3.3 Effect of Repeated Contraction on Ta
Inherent in the full L-T protocol is a series of repeated contractions, each at a different
length. With a focus on the ascending limb of the L-T curve, the effect of repeated
contraction at a single, shortened length 0.8-fold L0 on phasic and tonic Ta was assessed.
Additionally, the 3 min time point was assessed in an attempt to elucidate the transition
from phasic Ta at approximately 10-20 seconds to tonic Ta at approximately 5 min. An
example time versus tension tracing for 5 repeated contractions is shown in Figure 3.4A
with the average phasic, 3 min and tonic Ta achieved in Figure 3.4B. Phasic and tonic Ta
did increase with repeated contraction, with the greatest increase between T1 and T2
followed by T2 to T3. Relative to T1, there was no significant increase in phasic or tonic Ta
at T5 versus T3 (Figure 3.4C). The Ta at 3 min was also increased with repeated
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FIGURE 3.4: Effect of Repeated Contraction at a Shortened Length
Panel A shows a representative time versus tension tracing for a series of five repeated
contractions at a shortened length 0.8-fold L0. Panel B illustrates the average increase in
phasic, 3 min, and tonic Ta over the series of five contractions. Panel C shows that there is
only significant improvement in the 3 min time point beyond T3. ∗ indicates p< .05 for
T3/T1 versus T5/1. n=7.
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contraction, however, a significant increase relative to T1 was found between T3 and T5
(p<.05).
Thus, three contractions appeared appropriate to study L-adaptation of phasic and
tonic Ta. Additionally, these data suggested that either the activation process or the
additional time necessary for additional contractions will result in higher Ta at the 3 min
time point.

3.4 Effect of Time and Duration of Contraction on Ta
Due to the lengthy nature of the full L-T protocol, the effect of time on Ta
development was considered. The phasic, 3 min, and tonic Ta developed in a tissue at a
shortened length 0.8-fold L0 at time zero was compared to the same time points in a second
tissue that was activated 100 min later (T1-delay; Figure 3.5A). Only the 3 min time point
was found to be significantly (p<.05) improved in the delayed contraction (Figure 3.5B).
Therefore, it appeared that time alone will improve the Ta achieved at the transitional 3
min time point in a rabbit femoral artery contraction.
In the full L-T curve protocol, the duration of the contraction at each length step
was 7 min. The effect of a longer duration of a K+-induced contraction was thus
investigated. Tissues that remained activated for greater than 10 min demonstrated an
additional rise in Ta beyond that achieved during the tonic phase. This second rise achieved
a maximum (MAX) in an average of 34 min. When compared to the phasic, 3 min and
tonic Ta achieved during the third of three repeated contractions, where L-adaptation
47

1.0

A.

1.0
T1-delay

T1

0.8

0.8
0.6

T/T 0

0.6

T/T 0

C.

0.4

0.4

0.2

0.2

0.0

0.0

-0.2

-0.2
0

Max

15 30 130 140 150

0 10 20 30 40 50 60

Time (min)

Time (min)
B.

1.0

∗

20
15
10

0.6
0.4

5

0.2

0

0.0
Ph

3'

D.

0.8

T/T 0

% Improvement

25

Max Ph

Tn

48

3' Tn
T3

FIGURE 3.5 (on previous page): Effect of Delayed and Sustained Contraction at
Shortened Length
Panel A shows a representative time versus tension tracing for a contraction 100 min after
(T1-delay) a reference contraction (T1). Panel B shows that only the 3 min time point was
significantly improved (p< .05) in the T1-delay contraction relative to T1. Panel C shows a
representative time versus tension tracing for a sustained contraction, noting an additional
increase in tension beyond tonic, indicated by Max. Max Ta occurs at an average of 34
min after activation. Panel D indicates that the Ta achieved at Max of a sustained
contraction is not different from the Ta achieved during any phase of the third of 3 repeated
contractions (T3). n=7.
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appears complete, there were no differences (Figure 3.5D). Thus the same amount of Ta in
rabbit femoral artery can be achieved through either a sustained contraction of at least 34
min or a minimum of three repeated contractions.
Based on the above results, the 3 min time point was concluded to be an additional
phase of contraction that significantly increased with time alone. This time point did not,
however, provide additional information related to the phasic and tonic components of
contraction and was thus not used in further analyses.

3.5 L-adaptation of Ta at a Shortened Length
With three consecutive contractions of less than 34 min duration established as
appropriate to study the phasic and tonic phases of a rabbit femoral artery contraction, Ladaptation at a shortened length was further investigated.
First, the phasic and tonic Ta achieved with repeated contraction at length L0 were
investigated. No significant increase in either phase of T2 or T3, relative to T1 was found
(Figure 3.6A, Figure 3.6C and Figure 3.6D). Next, the phasic and tonic Ta achieved with
repeated contraction at a shortened length 0.8-fold L0 were studied. Relative to T1, both
phases were significantly greater during T2 and T3 (Figure 3.6B, Figure 3.6C and Figure
3.6D).
With L-adaptation defined as the increase in tension with repeated contraction, it was
important to quantify the amount of increased Ta by the third repeated contraction at a
shortened length. Relative to L0, the phasic Ta at 0.8-fold L0 increased an average of
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FIGURE 3.6 (on previous page): Effect of L-adaptation at a Shortened Length on
Phasic Ta and Tonic Ta
Panels A and B are representative time versus tension tracings for repeated contraction at
L0 and 0.8-fold L0, respectively. In Panel C, the average phasic Ta, relative to T1, achieved
over two subsequent contractions is shown for length 1.0-fold L0 and 0.8-fold L0. In Panel
D, the average tonic Ta, relative to T1, achieved over two subsequent contractions is shown
for each length. ∗ indicates p< .05 between lengths at either T2 or T3. n= 9-10.
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14.72% (SEM = 3.19, n=9) while the tonic Ta increased 9.87% (SEM = 3.24, n=9). These
increases in Ta were significant as shown in Figure 3.7.
In conclusion, L-adaptation does not occur at length L0, but does occur at a shortened
length of 0.8-fold L0. Additionally, although there was a larger percent increase in Ladaptation in the phasic phase versus tonic phase, this difference was not statistically
significant.

3.6 Role of [Ca 2+]i in L-adaptation of Ta at a Shortened Length
The results presented thus far indicate that while L-adaptation does not occur at length
L0, it does occur at shortened length 0.8-fold L0. Thus having characterized L-adaptation
in rabbit femoral artery, insight into a cellular mechanism was of interest. Based on the
known mechanism of smooth muscle contraction (refer to Figure 1.1) and the role that
Ca2+ plays in cell signaling, a role for [Ca 2+]i to mediate the increase in Ta with Ladaptation was investigated.
The [Ca 2+]i signal, as measured with the calcium indicator fura, was measured
simultaneously with Ta during the L-adaptation protocol just described. Relative to T1, a
significant increase in phasic and tonic Ta was again seen at T2 and T3 (Figure 3.8C and
Figure 3.8E). However, there were no significant differences in the simultaneous Ca2+
signal obtained during either phase of T2 nor T3 (Figure 3.8D and Figure 3.8F). It should
be noted that in these set of experiments, relative to T1, there was a decrease in phasic Ta at
length L0 at T3 and an increase in phasic Ta at length 0.8-fold L0. However, when taken
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FIGURE 3.7: L-adaptation at a Shortened Length of the Phasic and Tonic Phase
Bar graph illustrating the increase in phasic and tonic Ta on the third repeated contraction
at shortened length 0.8-fold L0, thus L-adaptation. ∗ indicates p< .05 versus 0. n= 9.
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FIGURE 3.8 (on previous page): Effect of [Ca 2+]i on L-adaptation at a Shortened
Length
Panel A is a representative time versus tension tracing that was obtained simultaneously
with the [Ca 2+]i signal represented in Panel B. Panels C and E demonstrate phasic and
tonic Ta L-adaptation as previously discussed. Panels D and F indicate no significant
changes in the [Ca 2+]i signal for the phasic nor tonic components of contraction relative to
T1. ∗ indicates p< .05 between lengths at either T2 or T3. n= 4.
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together there was significant phasic L-adaptation at T3. Despite a trend toward an
increase, at no time point, during either phase, was the Ca2+ signal significantly different
relative to T1. Thus, the increase in Ta evident with repeated contraction does not appear to
be mediated through an increase in [Ca 2+]i , as measured at approximately 20 sec (phasic)
and 10 min (tonic) into contraction.

3.7 Role of MLC20 Phosphorylation in L-adaptation of Ta at a Shortened Length
Phosphorylation of MLC20 is another important point of regulation in smooth
muscle contraction and was thus investigated as a possible participant in L-adaptation. For
the myosin phosphorylation studies, one modification was made to the L-adaptation
protocol previously described. To capture any length-dependent differences in
phosphorylation that may exist, the difference in the lengths compared were exaggerated.
In the L-adaptation experiments previously described, length L0 was used as a control. In
the myosin phosphorylation experiments, all tissues were adapted to a longer length, 1.25fold L0, to serve as control. In the L-adaptation experiments previously described, 0.8-fold
L0 was used as a shortened length at which L-adaptation occurs. In the myosin
phosphorylation experiments, tissues were released to shortened length 0.75-fold L0. For
both control and shortened lengths, tissues were then quick-frozen at one of the following
four time points: (1) basal level prior to T4, (2) steady state K+-induced T4 contraction, (3)
basal level prior to T6 or (4) steady state K+-induced T6 contraction (Figure 3.9A and B).
Relative to T4, there were no differences in basal levels of tension of T6 at 0.75-fold L0 as
compared to 1.25-fold L0. However, there was significantly more tension generated at the
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FIGURE 3.9 (on previous page): Effect of MLC20 Phosphorylation on L-adaptation at
Shortened Length
The top portions of Panel A and Panel B illustrate protocol length changes while the
bottom portions are representative time versus tension tracing for tissues adapted at 1.25fold L0 (A) and 0.75-fold L0 (B). All tissues were first stretched to 1.30-fold L0 to allow
for stress relaxation before release and adaptation at 1.25-fold L0. Panel C demonstrates
the increase in Ta at shortened length 0.75-fold L0 while Panel D illustrates no changes in
MLC20 phosphorylation with K+-activation. F indicates a time point at which a tissue was
quick frozen. ∗ indicates p< .05 between lengths at either basal or during activation. n= 4.
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shortened length, as compared to the control length, with K+-activation (Figure 3.9C).
Western blot analysis demonstrated a significantly lower amount of basal MLC20
phosphorylation at control length relative to shortened length, but no length-dependent
differences upon K+-activation (Figure 3.9D). Thus, an increase in MLC20
phosphorylation does not appear responsible for the increase in Ta generated with repeated
contraction at a shortened length.

3.8 Effect of Inhibitors of Actin Polymerization on Contraction at L0
As L-adaptation was not explained by an increase in [Ca2+]i nor an increase in
phosphorylated MLC20, a role for regulation of actin thin filaments was investigated.
Before the effect of inhibitors of actin polymerization could be assessed in a series of three
repeated contractions at shortened length, their effect on a K+-induced contraction at L0
was assessed. Depending on the mechanism by which each drug prevents actin
polymerization, differential effects on the phasic and tonic phase were evident.
Cytochalasin D inhibits actin polymerization by capping the (+) end of F-actin and
thus prevents the addition of G-actin. When 0.2 µM cytochalasin D was added between
two consecutive contractions at L0, there was a significant decrease in both phasic and
tonic Ta (Figure 3.10B). Following an additional 4 contractions, cytochalasin D further
reduced the phasic and tonic Ta such that phasic and tonic phases produced nearly
equivalent amounts of tension. When the data was analyzed as a percent inhibition of the
pre-drug contraction, there was significantly more inhibition at T6 versus T2, and in the
tonic component versus the phasic component (Figure 3.10C). Thus, through this indirect
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FIGURE 3.10 (on previous page): Effect of Inhibitors of Actin Polymerization on
Contraction at L0
Panels A, D and G illustrate representative time versus tension tracings for repeated
contractions at L0 in the presence of 0.2 µM cytochalasin D, 2 µM latrunculin B and 0.3
µM H-1152, respectively. The introduction of drug is indicated by the arrow. Panels B, E
and H show the normalized tension prior to introduction of cytochalasin D, latrunculin B
and H-1152, respectively, and then post-drug at T2 and T6 with ∗ indicating p< .05
differences relative to T1. Panels C, F and I illustrate the percent inhibition of phasic and
tonic Ta relative to T1 for cytochalasin D, latrunculin B and H-1152, respectively
with ∗ indicating p< .05 between T2 and T6 and ψ indicating p< .05 between phases.
n= 5-6.

62

measure, an increase in F-actin appears to play a role in both the phasic and tonic
components of contraction with a larger effect on the tonic phase.
Latrunculin B inhibits actin polymerization by binding 1:1 with free G-actin
monomers. Similar to cytochalasin D, when 2 µM latrunculin B was added between two
consecutive contractions at L0, there was a significant decrease in both phasic and tonic Ta
(Figure 3.10E). An additional 4 contractions in the presence of latrunculin B further
reduced the phasic and tonic Ta, with a greater effect on the tonic phase. Compared to the
pre-drug contraction, there was almost complete inhibition of the tonic phase after four
contractions (Figure 3.10F). Thus, although cytochalasin D and latrunculin B significantly
inhibit the tonic phase more than phasic phase, quantitatively, the effect appeared greater
in the presence of latrunculin B. Thus, it appears that free G-actin monomers are necessary
for both phases of VSM contraction, with the lack thereof more pronounced in the tonic
phase.
Through ROCK, Rho is thought to stabilize cofilin and activate profilin, thus
providing a stable actin cytoskeleton. H-1152 is an inhibitor of ROCK and thus has effects
on the stability of the actin cytoskeleton. When 0.3 µM H-1152 was added between two
consecutive contractions at L0, there was a significant decrease in the tonic phase only
(Figure 3.10H and I). Additionally, although the decrease in tonic Ta remained significant
following four contractions as compared to pre-drug, there was no progressive inhibition of
the tonic phase with repeated contraction (Figure 3.10I). Thus, it appears that Rho is
important in only the tonic phase of contraction presumably through its effect on cofilin
and profilin.
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In conclusion, these studies demonstrate that actin polymerization is a necessary
component of rabbit femoral artery contraction, with the effects more prominent in the
tonic phase of contraction.

3.9 Role of [Ca2+]i as Mediator of Inhibition of Actin Polymerization
In the presence of cytochalasin D and latrunculin B, a decrease in the phasic and tonic
Ta generated by rabbit femoral artery was evident. The possibility that these agents
inhibited contraction by blocking Ca2+ channels was considered. Thus a series of
experiments were completed that investigated [Ca2+]i in the presence of inhibitors of actin
polymerization.
Using the same protocol illustrated in Panels A, D and G in Figure 3.10, simultaneous
tension and [Ca2+]i measurements were obtained. As previously shown, relative to predrug, there was a significant decrease in both phasic and tonic tension in the presence of
0.2 µM cytochalasin D (Figure 3.11A). This decrease did not appear to be due to a
decrease in Ca2+ as phasic [Ca2+]i remained the same as pre-drug and tonic [Ca2+]i
significantly increased (Figure 3.11B). The same trends were true in the presence of 2 µM
latrunculin B. In the presence of decreased tension generation, phasic [Ca2+]i was not
changed and tonic [Ca2+]i significantly increased (Figure 3.11C and D). Thus, a concurrent
decrease in [Ca2+]i did not appear responsible for the decrease in Ta evident when actin
polymerization is inhibited. It is interesting to note that [Ca2+]i during the tonic phase of
the contraction significantly increased while the Ta has significantly decreased.
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FIGURE 3.11: Effect of Inhibitors of Actin Polymerization on [Ca 2+]i on Contraction
at L0
Bar graphs illustrating significant decreases in phasic and tonic Ta in the presence of 0.2
uM cytochalasin D (Panel A) and 2 uM latrunculin B (Panel C). During simultaneous
[Ca2+]i measurements in the presence of each drug, phasic Ca2+ remained the same as predrug while tonic Ca2+ significantly increased. ∗ = p< .05 relative to pre-drug. n=3.
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3.10 Effect of Inhibitors of Actin Polymerization on L-adaptation of Ta at a Shortened
Length
Having established the effect of actin polymerization on the development of phasic
and tonic Ta in rabbit femoral artery maintained at L0, it was of interest to investigate the
role of actin polymerization on the L-adaptation of phasic and tonic Ta at a shortened
length. The protocol utilized to investigate cytochalasin D, latrunculin B and vehicle
control DMSO was previously presented in the Figure 2.6 of the Materials and Methods.
The complex nature of the protocol and data analysis warrants further description before
the results are presented.
Following introduction of the drug and two contractions at L0, one tissue was
maintained at length L0 while a second tissue was released to shortened length 0.8-fold L0
for three remaining contractions in the protocol (T4, T5, and T6). Representative time
versus tension tracings at lengths L0 and 0.8-fold L0, respectively, are shown for DMSO
(Figure 3.12 Panel A and B), cytochalasin D (Figure 3.12 Panel C and D) and latrunculin B
(Panel E and F). First, all phasic and tonic Ta achieved at T6 were normalized to its own Ta
achieved during T4 to account for individual differences in tissues. Next, data at 0.8-fold
L0 was normalized to data at L0 to account for the effect of the drug on contractions at L0.
The increase in force above 1, indicating no difference in generation of Ta between T4 and
T6, was converted to a percentage and interpreted as the amount of L-adaptation the tissue
displayed.
For ease of comparison, the L-adaptation that tissue displays in the absence of drug
illustrated in Figure 3.7 is shown again in Panel A of Figure 3.13. Both phases of a
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FIGURE 3.12 (on previous page): Representative Tension Tracing in the Presence of
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Representative time versus tension tracings for the investigation of L-adaptation of Ta over
three contractions at length L0 and 0.8-fold L0. Panel A and B illustrate vehicle control
DMSO, Panels C and D 0.2 µM cytochalasin D and Panels E and F 2 µM latrunculin B.
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femoral artery contraction demonstrate a significant increase in Ta, on average 15% for the
phasic component and 10% for the tonic component. The vehicle control (DMSO) for
cytochalasin D and latrunculin B does not affect adaptation as there is an average of 15%
increase in the phasic phase and 9% increase in the tonic phase (Figure 3.13B). In
contrast, there is loss of significant adaptation in the presence of cytochalasin D, with less
than 1% adaptation in both phases (Figure 3.13C). In the presence of latrunculin B,
significant adaptation of the phasic phase remains (24%) while the 7% L-adaptation of the
tonic phase is not significant (Figure 3.13D). Thus, although actin polymerization is
necessary for L-adaptation of phasic and tonic Ta in femoral artery, with significant phasic
adaptation in the presence of latrunculin B, it appears that the source of G-actin is one
other than free monomers in the cytosol.
The effect of ROCK inhibition was also investigated. In the presence of H-1152,
significant adaptation of 19% remained while the 6% adaptation in the tonic phase was not
significant (Figure 3.13E). Thus, ROCK appears to play a significant role in the tonic
phase of L-adaptation.
To further investigate a possible role for Ca2+ participation in L-adaptation of Ta, the
effect of the L-type Ca2+ channel blocker nifedipine on L-adaptation was investigated.
When used at 10 nM, significant adaptation in phasic (9.7%) and tonic (13%) Ta remained
(Figure 3.13F).
In summary, these results demonstrate that phasic L-adaptation is dependent, at least
in part, on the growth of actin through the addition of G-actin monomers to F-actin. Tonic
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nM nifedipine (Panel F). ∗ = p< .05 compared to 0. n= 5-12.

71

L-adaptation appears to be more complex and appears to be affected not only by
availability of the (+) end of F-actin to which G-actin monomers can add but also the
activity of regulators of actin polymerization (i.e. cofilin and profilin).

3.11 L-adaptation of Ta at a Shortened Length in β-escin Permeabilized Tissue
A possible role for Ca2+ was further investigated in β-escin permeabilized tissue of
rabbit femoral artery. With the selective damage to cellular processes inherent in a
permeabilized tissue preparation there is a gradual decrease in the tension generation with
time and repeated contraction (Figure 3.14A). Despite this difficulty, L-adaptation of Ta
was studied at optimal length and a shortened length through activation with pCa 6.0. Due
to the nature of the muscle activation in this preparation, only the steady-state phase of
contraction was investigated in this preparation. Panel B in Figure 3.14 illustrates the
gradual decrease with time and four repeated contractions in tissues at length L0 and at 0.8fold L0. Thus, to study L-adaptation in this preparation, differences in the rate of
degradation between the two lengths were interpreted as “apparent adaptation.” In Figure
3.14C, apparent adaptation was significant in the third and fourth repeated contraction at
0.8-fold L0 relative to L0. Significant steady-state apparent L-adaptation remained in the
presence of cytochalasin D, latrunculin B and H-1152 (Figure 3.14D).
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Panel A illustrates representative time versus tension tracing in a β-escin permeabilized
tissue preparation with muscle activation with pCa 6.0. Panel B demonstrates the average
tensions generated over 4 contractions at length L0 and 0.8-fold L0. Panel C demonstrates
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74

3.12 Effect of Inhibitors of MLCK on L-adaptation of Ta at a Shortened Length
As studies with fura Ca2+ indicating dye, nifedipine and permeabilized tissue
preparation did not demonstrate a role for Ca2+ in the L-adaptation of Ta, the next
downstream molecule, calcium-calmodulin (Ca2+-CaM), was briefly investigated. In
addition to calmodulin, another intracellular Ca2+ binding partner is Ca2+-calmodulindependent protein kinase II (CaMKII),which has been shown to be activated with K+stimulation and suggested to play a role in maintenance of tonic Ta in VSM (Rokolya and
Singer 2000). To study L-adaptation, a series of three contractions (T1, T2, T3) were
completed either at L0 or 0.8-fold L0 in the presence of KN-93, a CaMKII inhibitor, or KN92, a negative control for KN-93. As KN-92 is dissolved in DMSO and KN-93 is
dissolved in deionized water, additional controls included measurement of L-adaptation in
the presence of DMSO or deionized water and phentolamine. Figure 3.15 illustrates
example tension versus time tracings for tissues at 0.8-fold L0 in the presence of deionized
water (Panel A), DMSO (Panel B), KN-92 (Panel C) and KN-93 (Panel D). Regardless of
length, tissues in the presence of KN-93 demonstrated decreases in both phases of
contraction, with effects more pronounced in the tonic phase. The effect of KN-93 and
KN-92 were investigated in tissues from the same animal, however, length differences
were investigated between animals and thus statistics not completed. Therefore, when data
from different animals were randomly paired, a decrease in both phases of Ta generation
was evident when CaMKII was inhibited (Figure 3.16 E and F).
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FIGURE 3.16 (on previous page): Effect of CaMKII Inhibitor on L-adaptation of Ta
at a Shortened Length
Average Ta over three repeated contractions at length L0 (Panel A and B) and 0.8-fold L0
(Panel C and D) in the presence of KN-92 and KN-93. Panel E and Panel F demonstrate
an increase in phasic and tonic Ta KN-92 tissues relative to KN-93 tissues. ∗ indicates p<
.05 between drugs. n= 3 at each length.
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3.13 Effect of Stretch versus Stretch and Contraction on L-adaptation of Ta at a
Shortened Length
Having started this project with an investigation of the effect of stretch on Tp, in a last
series of experiments, the effect of stretch on L-adaptation of Ta at a shortened length was
studied. All tension measurements were taken at 0.8-fold L0, however, a stretch to 1.2-fold
L0 was completed between T1 and T2 (Figure 3.17A). While stretch was thought to break
intracellular and/or extracellular connections, the effect of a contraction at a stretched
length was also investigated (Figure 3.17B).
Relative to pre-stretch (T1), both the phasic and tonic Ta in a contraction poststretch (T2) was significantly decreased (Figure 3.17C and D). This was also seen in
tissues subjected to contraction at long length. Phasic and tonic Ta returned to levels at or
above pre-stretch upon a subsequent third contraction (T3). It is interesting to note that the
addition of a contraction at long length significantly decreased tonic Ta as compared to
stretch alone (Figure 3.17 D). The decrease in phasic and tonic Ta generation was more
pronounced with a greater stretch to 1.4 L0 (data not shown). Decreased [Ca2+]i levels do
not appear to play a role in the decreased phasic and tonic Ta generation following stretch
or stretch and contraction (Figure 3.18).
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FIGURE 3.17 (on previous page): Effect of Stretch versus Stretch and Contraction
on L-adaptation of Ta at a Shortened Length
Representative time versus tension tracing of 3 consecutive contractions, T1, T2, and T3, at
a shortened length 0.8 L0 with a stretch to 1.2 L0 completed between T1 and T2 (Panel A)
and contraction at the stretched length completed between T1 and T2 (Panel B). Average
phasic (Panel C) and tonic (Panel D) tension values normalized to T1 over 3 consecutive
contractions are shown. Note additional decrease in tension in tissue when contraction
completed at the stretched length. ∗ indicates p< .05 stretch compared to stretch + contract
for a single contraction. ψ = P< .05 compared to 1.0. n = 5-11.
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FIGURE 3.18: Effect of [Ca 2+]i on Stretch versus Stretch and Contraction
Panel A shows the average phasic and Panel C shows the average tonic tension values
normalized to T1 over three consecutive contractions at length 0.8 L0 with stretch to 1.2 L0
completed between T1 and T2 or stretch and contraction completed between T1 and T2.
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single contraction. ψ = P< .05 compared to 1.0. n = 3.
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CHAPTER 4
Discussion
The main findings of this project include the presence of a dynamic Tp and Ta L-T
curve in rabbit femoral artery and that tissues contracted three times at a shortened length
displayed significant L-adaptation in both the phasic and tonic phases. Attempts to
elucidate a mechanism for this phenomenon showed that neither an increase in [Ca2+]i nor
an increase in MLC20 phosphorylation were responsible for the increased tension, however,
actin polymerization did appear to play a role in the L-adaptation of both phases of
contraction (Figure 4.1).
With the awareness that the length-history of VSM affects the Tp at a particular
length, and to facilitate comparison between studies, the method utilized to measure Tp in
this project was a modification of that used previously [37, 121]. With a focus on the
ascending limb of the L-T curve, similar to the results of Wingard et al. [121], two Tp
curves were found with the tension greater with tissue LD versus tissue ULD. Wingard et
al. attributes this difference to tissue damage that occurs with stretch to long lengths such
that there is a subsequent decrease in viable VSM capable of generating tension. In
separate experiments, tissues naïve to maximal stretch (1.4-fold L0) demonstrated a
significant increase in Tp upon first stretch to 1.2-fold L0 as compared to a second stretch
to 1.2-fold L0 in the same tissue or another tissue previously stretched to 1.4-fold L0.

83

Activation of Muscle Cell
[Ca2+]

Ca2+-CaM
Tension
Active Crossbridge

MLCK
MLC

MLCp + Actin
MLCP

ROCK

PKC

Dense Body

Adhesion Junction
Extracellular Matrix
FIGURE 4.1: Diagram of Mechanism of Smooth Muscle Contraction Relative to Ladaptation at a Shortened Length
Diagram illustrating the mechanism of smooth muscle contraction, from activation through
transmission of generated tension to the extracellular matrix. Note that results of this
project provided evidence that neither [Ca2+]i nor MLC20 phosphorylation were responsible
for L-adaptation, however, actin polymerization does play a role.
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Although it is possible that tissue damage was responsible for this difference, it was not
thought to be likely based on further interpretation of the full L- T curve results. In this
protocol, tissues were preconditioned, activated at a series of increasing lengths, activated
at a series of decreasing lengths followed by measurement of Tp. Due to stress relaxation,
to obtain a true Tp at the longest length, tissues were stretched to a length 0.05 mm longer
than at any time previously in the protocol. Although it is possible that this stretch of less
than 2% of the L0 resulted in tissue damage, and thus the decreased Tp with ULD, it is not
thought to be likely as it has been estimated that the series elastic component in VSM is
not affected until lengths 7.2% of L0 [38]. Additional studies are necessary to determine
the mechanism responsible for the difference in Tp with LD and ULD. A possible role for
crossbridges in generating Tp exists as Speich et al. found that activation can reverse the
effect of strain-softening in rabbit detrusor smooth muscle [100, 101].
Furthermore, the presence of the two Ta curves agrees with the findings of Wingard
et al. [121]. However, again, tissue damage was not thought to be responsible as the
increased Ta with LD versus ULD was found when tissues were first gradually shortened
and then gradually lengthened (data not shown). The presence of two L-Ta curves for each
phase of contraction was a novel finding in this study and further investigation revealed
that the tonic phase was more sensitive to length changes below L0 as compared to the
phasic phase.
The L-adaptation in VSM demonstrated in the present project confirmed the
findings of the two previous studies by Seow [91] and Syyong et al. [104]. Seow reported
that L-adaptation was dependent on time, however, the protocol used to adapt the tissues
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included periodic muscle activation. Thus, in this project, the effect of time versus
repeated contraction at a single length was more fully investigated. It appeared that the
effect of time on Ta is dependent on the state of the muscle, relaxed or contracted. When a
relaxed tissue was contracted 100 min after a second reference tissue, the phasic and tonic
Ta were not significantly different between tissues (Figure 3.5B). However, when a tissue
was maintained in a contracted state for 120 min, the maximal Ta was not significantly
different than phasic nor tonic Ta of a third repeated contraction (Figure 3.5D). Thus, the
maximal Ta of VSM can be achieved through a sustained contraction of average 34 min
duration or upon a third repeated contraction.
This project appears to be the first to determine a cellular mechanism(s) responsible
for L-adaptation at a shortened length in VSM. Both phases of contraction demonstrated
L-adaptation but were investigated separately throughout all experiments. As the
mechanism(s) responsible for each phase are not fully understood, it was hoped that the
phenomenon of L-adaptation might be used as tool to reveal information about the
mechanisms regulating these phases.
The importance of Ca2+ as a signaling molecule in the regulation of crossbridges in
smooth muscle is well known. Some have observed a decrease in myoplasmic [Ca2+]i in
VSM at short lengths [83] while others have not found the same in ASM [32]. Therefore,
in a series of three separate experiments, the possibility that an increase in [Ca2+]i was
responsible for the increased tension evident with repeated contraction at a shortened
length was investigated. The first set of experiments utilized a Ca2+-indicating dye and did
not show a length dependent difference in [Ca2+]i with repeated contraction. Of note,
86

similar to the studies in ASM, [Ca2+]i trended toward an increase during both phases of
contraction at a shortened length and the phasic phase at length L0. Ratz et al. [80]
previously showed that [Ca2+]i in VSM trends toward an increase upon a second
contraction at length L0. A second set of experiments investigating the role of [Ca2+]i
involved a β-escin permeabilized tissue preparation. With the disruption of the cell
membrane, the amount [Ca2+]i available for muscle contraction can be precisely controlled
through the contracting solution. When tissue was activated with a constant pCa 6.0
solution, the apparent L-adaptation at a shortened length was evident in this preparation
and was taken as evidence that an increase in [Ca2+]i was not responsible for the increase in
tension with repeated contraction. A third, and final, set of experiments provided evidence
that [Ca2+]i was not playing a role in L-adaptation. In the presence of a low concentration
of the L-type Ca2+-channel blocker nifedipine, the tissue continued to display a significant
phasic and tonic L-adaptation at a shortened length.
Having explored an upstream regulator of VSM contraction, attention was turned
further downstream to regulation of crossbridge activation through phosphorylation level
of MLC20. Using a modified protocol to capture small differences in phosphorylation that
may exist between tissues at a control length and tissues at shortened length, no difference
in phosphorylation levels were found to correspond with the increase in Ta with repeated
contraction. Interestingly, a significant decrease in the basal myosin phosphorylation was
found by the third repeated contraction in control length tissues despite lack of a decrease
in Ta. Hai [34] reported that steady-state active stress and myosin phosphorylation were
not different between two repeated contractions at length L0. Although no statistical
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differences were presented, from the data included, a trend toward a decrease in levels of
myosin phosphorylation with a second repeated contraction is evident. As compared to a
shortened length, the decreased basal levels of myosin phosphorylation at control length
should be considered as a possible contributor to the lack of differences with K+-induced
activation. Further studies investigating basal levels of myosin phosphorylation at
different tissues lengths with repeated contraction are warranted.
As changes in myosin based regulation of crossbridge activation did not appear
responsible for L-adaptation, attention was turned to the actin thin filament. As compared
to striated muscle, there is a greater actin to myosin ratio present in smooth muscle. Thus,
the possibility exists that polymerization of actin upon muscle activation results in the
formation of additional crossbridges with resultant increase in tension. Previously, others
[4, 123] have shown the effect of the F-actin capping agent cytochalasin to be limited to
the slow phase of contraction in rat aortic rings. While the present results demonstrated an
effect greater in the tonic phase, significant inhibition was evident in both phases that
increased with repeated contraction at L0 (Figure 3.10 B and C). Likewise, some have
found no effect of latrunculin B on a K+-induced contraction [47] while the results
presented here indicated increased inhibition with repeated contraction in both the phasic
and tonic phases of an L0 contraction (Figure 3.10 E and F). Reasons for these differences
are not known but may be tissue or drug concentration dependent. When the effect of the
ROCK inhibitor H-1152, known to affect actin polymerization through LIMK1 and cofilin,
were investigated at length L0, there was no effect on the phasic phase but a significant
inhibition of the tonic phase, which is consistent with previous work [80] (Figure 3.10 H
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and I). The effects of cytochalasin B do not appear to be mediated through changes in
[Ca2+]i. (Figure 3.11 B), in agreement with work by Obara and Yabu [67], nor do the
effects of latrunculin B appear Ca2+-mediated (Figure 3.11 D).
The possible effect of inhibition of actin polymerization on L-adaptation in VSM
was investigated. For both phasic and tonic Ta, within tissue differences between
contractions and the differential effect of length on the Ta generated in the presence of the
inhibitor were accounted for. The results indicated that the addition of G-actin monomers
to the (+) end of F-actin is necessary for L-adaptation of both the phasic and tonic phases
of VSM contractions, evident with the results in the presence of cytochalasin D (Figure
3.13C). Additionally, it appears that different sources of G-actin are responsible for the
actin polymerization necessary for each phase, with the source for the tonic phase
including free G-actin monomers as evident with the lack of significant L-adaptation in the
presence of latrunculin B (Figure 3.13D). Although speculative, an alternative source of
G-actin for the phasic phase could theoretically include G-actin bound to thymosin β4 that
is freed upon muscle activation to participate in actin polymerization. The results of Ladaptation in the presence of H-1152 indicate that actin polymerization involving ROCK is
limited to the tonic phase as phasic L-adaptation remained. The importance of actin
polymerization in the tonic phase of VSM contraction has been previously shown in
studies such as that by Rembold et al. [84], however, the role of actin polymerization in the
phasic phase appears to be a novel finding in this project.
The role of crossbridge regulation through the myosin thick filament was
investigated in this project and not found to affect L-adaptation in VSM. Structural
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changes in the actin thin filament, through polymerization, were, however, found to
participate in L-adaptation. A possibility for future studies would involve investigation of
crossbridge regulation through the actin thin filament. Two possible actin-binding proteins
that are thought to participate in regulation of actin include caldesmon and calponin
(reviewed in [62]). Capable of binding with actin, tropomyosin, myosin and calmodulin,
caldesmon is uniquely situated to affect crossbridge function. Through its ability to bind
with actin, calponin has been suggested to participate in crossbridge regulation through
inhibition of the myosin ATPase.
Another signaling molecule, CaMKII, was briefly investigated in this project. As
reviewed by Kamm and Stull [46], at higher [Ca2+]i than necessary to activate MLCK and
thus increase MLC20 phosphorylation, CaMKII is activated and can phosphorylate MLCK
at a site that will result in the dissociation of calmodulin and thus decrease its activity. It is
thus possible that inhibition of CaMKII, through an agent such as KN-93, will limit the
normal inhibition of MLCK present at higher [Ca2+]i and result in increased tension
generation. In contrast to what was expected, yet consistent with the findings of others [48,
86], the present results indicated that there was a decrease in both phasic and tonic tension
at L0 and 0.8-fold L0 with KN-93. In the presence of the negative control, KN-92, there
were minimal to no decreases in tension at the two lengths studied. Taken together, these
results indicated that L-adaptation at a shortened length is abolished for both the phasic
and tonic phases in the presence of KN-93 (Figure 3.16 E and F). The mechanism for
decrease in tension in the presence of a CAMKII inhibitor is not yet clear but involvement
of mitogen-activated protein kinase (MAPK) has been suggested [48]. A role for
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CaMKIIβ in maintaining polymerized F-actin in developing neurons has recently been
shown [52].
The effect of an interruption in L-adaptation was also briefly explored in this
project. With an intervening stretch or a contraction at a stretched length, a decrease in
both phasic and tonic Ta was evident (Figure 3.17) that did not appear to be the result of a
change in [Ca2+]i (Figure 3.18).
It is of particular clinical interest to consider the response of VSM stretch on
tension generation. Through continuous, intra-arterial blood pressure monitoring in both
normotensive and hypertensive patients it has been shown that blood pressure follows a
circadian rhythm [60]. In both groups, blood pressure was found to be highest midmorning and then progressively fell throughout the day and evening to reach a 24-hour low
at 3 AM. O’Brien et al. [68] reported “non-dippers” as a subset of hypertensive patients
who do not demonstrate the normal diurnal variation in blood pressure, as defined by a 10
mm Hg decrease in systolic blood pressure and a 5 mm Hg decrease in diastolic blood
pressure from day to night. The lack of a nocturnal decrease in blood pressure in these
hypertensive patients has been linked to stroke, left ventricular hypertrophy, heart failure,
myocardial infarction, and sudden death [68, 102, 116]. The mechanism responsible for
circadian rhythm of blood pressure is not yet fully understood, however, a role for the
sympathetic nervous system (SNS) has been suggested [72, 96]. A study by Sherwood et
al. [95] provided further evidence for the role of the SNS as it pertains to nocturnal
decreases in blood pressure. They found that the drop in excretion of urinary
catecholamines, from day to night, was significantly less in the “non-dipper” subjects.
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Additionally, they found that the subjects exhibited no difference in the responsiveness of
β-adrenergic receptors, however, “non-dippers” demonstrated an increase in α1-receptor
sensitivity compared to “dippers.” Thus, the authors concluded that the higher level of
nighttime blood pressure in “non-dippers” may be due to an increased vasoconstriction,
with resultant increased TPR. Thus with evidence of more than one L-Ta curve in VSM,
the possibility exists that the arteries of “non-dippers” are unable to adapt to another curve
when blood pressure is typically lower during nighttime hours. For small resistance
arteries, this may result in changes in TPR while for larger conduit arteries this may result
in changes in stiffness.
The L-adaptation studied in this project was of a relatively short duration. A study
by Naghshin et al. [64] demonstrated that following longer term (7 days) adaptation at a
shortened length in ASM, re-adaptation to a longer length became more difficult to
complete. The authors note that perhaps chronic effects may be reversed if the muscle was
adapted to the longer length over a longer period of time. Thus the possibility of
remodeling of arteries chronically adapted to a short length exists. As reviewed by
Prewitt, Rice and Dobrian [75], vessels are capable of different types of remodeling,
dependent on their size. The arterioles undergo an inward, eutrophic remodeling in which
lumen diameter is reduced while wall thickness is maintained. This is in contrast to the
outward hypertrophy remodeling that large arteries undergo in which luman diameter is
maintained while wall thickness increases. As previously presented, a role has been
suggested for integrins and focal adhesion proteins as tranducers of mechanical stimuli to
intracellular signaling. Thus, these important sites on the smooth muscle cell membrane
92

may provide a possible link between actin polymerization that appears to play a role in Ladaptation at a shortened length and consequent long term remodeling of the arterial tree.
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